Karel Deblaere Selected Research

Neoplasms (Cancer)

1/2024	Integrating and optimizing tonabersat in standard glioblastoma therapy: A preclinical study.
5/2019	Technical feasibility of [18F]FET and [18F]FAZA PET guided radiotherapy in a F98 glioblastoma rat model.
1/2019	Adjuvant therapeutic potential of tonabersat in the standard treatment of glioblastoma: A preclinical F98 glioblastoma rat model study.
1/2019	The Path Toward PET-Guided Radiation Therapy for Glioblastoma in Laboratory Animals: A Mini Review.
1/2015	(18)F-fluoromethylcholine (FCho), (18)F-fluoroethyltyrosine (FET), and (18)F-fluorodeoxyglucose (FDG) for the discrimination between high-grade glioma and radiation necrosis in rats: a PET study.
11/2014	MRI-guided 3D conformal arc micro-irradiation of a F98 glioblastoma rat model using the Small Animal Radiation Research Platform (SARRP).
12/2013	Spontaneous delayed brain herniation through a subdural membrane after tumor surgery.
8/2012	Distribution patterns of 18F-labelled fluoromethylcholine in normal structures and tumors of the head: a PET/MRI evaluation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karel Deblaere Research Topics

Disease

9	Glioblastoma (Glioblastoma Multiforme) 01/2024 - 11/2014
8	Neoplasms (Cancer) 01/2024 - 08/2012
5	Glioma (Gliomas) 01/2024 - 01/2016
3	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021 - 05/2019
3	Diffuse Axonal Injury 01/2021 - 05/2019
2	Brain Neoplasms (Brain Tumor) 01/2024 - 01/2019
2	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2018
2	Necrosis 01/2016 - 01/2016
2	Epilepsy (Aura) 02/2004 - 12/2003
1	Migraine Disorders (Migraine) 01/2024
1	AIDS-Related Complex (ARC) 01/2021
1	Diaschisis 01/2020
1	Wounds and Injuries (Trauma) 01/2020
1	Wallerian Degeneration 01/2020
1	Brain Injuries (Brain Injury) 10/2019
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Subdural Effusion (Subdural Hygroma) 12/2013
1	Ophthalmoplegia (External Ophthalmoplegia) 04/2011
1	Ataxia (Dyssynergia) 04/2011
1	Temporal Lobe Epilepsy 09/2005

Drug/Important Bio-Agent (IBA)

5	fluoromethylcholineIBA 01/2021 - 08/2012
3	Temozolomide (Temodar)FDA LinkGeneric 01/2024 - 11/2014
3	salicylhydroxamic acid (SHAM)IBA 01/2021 - 11/2014
2	Connexin 43 (Connexin43)IBA 01/2024 - 01/2019
2	tonabersatIBA 01/2024 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2019
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2019
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2018
2	Tyrosine (L-Tyrosine)FDA Link 01/2019 - 01/2015
2	Amobarbital (Amsal)IBA 09/2005 - 02/2004
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021
1	fluoroazomycin arabinosideIBA 05/2019
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2019
1	ConnexinsIBA 01/2019
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 01/2019
1	ferric oxide (iron oxide)IBA 01/2018
1	Sodium Fluoride (Ossin)FDA Link 01/2018
1	Green Fluorescent ProteinsIBA 01/2018
1	Fluorine-18IBA 03/2017
1	Deoxyglucose (2 Deoxy D glucose)IBA 01/2015

Therapy/Procedure

6	Therapeutics 01/2024 - 02/2004
5	Radiotherapy 01/2024 - 12/2013
2	Drug Therapy (Chemotherapy) 01/2024 - 12/2013
1	Cognitive Training 10/2019
1	Adjuvant Chemotherapy 01/2019
1	Injections 11/2014
1	Cerebrospinal Fluid Shunts 12/2013
1	Secondary Prevention 04/2011
1	Deep Brain Stimulation 12/2003
1	Electrodes (Electrode) 12/2003